Quantcast

Latest abdominal aortic aneurysm Stories

2010-07-13 15:30:00

IRVINE, Calif., July 13 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2010 financial results, which will take place on Thursday, July 22, 2010 after the close of the market. Endologix will hold a conference call on Thursday, July 22, 2010 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic...

2010-07-12 05:45:00

REYKJAVIK, Iceland, July 12, 2010 /PRNewswire-FirstCall/ -- Points to Novel Pathway for Drug Discovery, Will be Incorporated Into Tests to Improve Screening and Early Detection of Abdominal Aortic Aneurysm, Heart Attack and PAD Scientists at deCODE genetics and academic colleagues from the Netherlands and twelve other countries across Europe and North America today report the discovery of a common single-letter variation (SNP) in the sequence of the human genome conferring risk of a...

2010-07-06 11:00:00

IRVINE, Calif., July 6 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has appointed Todd Abraham to the newly created position of Vice President of Operations. Mr. Abraham will be responsible for managing all of Endologix's day-to-day operations and will report to John McDermott, President and Chief Executive Officer. Mr. McDermott, said, "Todd Abraham is a 25 year veteran of the medical...

2010-06-18 14:56:41

Y chromosome linked to fatal aneurysm Research currently being undertaken at the University of Leicester may identify reasons underlying an increased risk of Abdominal Aortic Aneurysms (AAA) in men. In her doctoral study, Cardiovascular Sciences student Lisa Bloomer is looking into the causes of the male predominance of AAA, with a particular emphasis on genetic basis of the disease. Preliminary results from the study will be showcased at the University of Leicester's Festival of Postgraduate...

2010-06-10 08:00:00

IRVINE, Calif., June 10 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of Powerlink® stent graft products. The approval covers 31 new sizes of Powerlink® main body bifurcated, proximal extension, and limb extension stent grafts that increase the system's addressable...

2010-06-07 12:04:00

BOSTON, June 7 /PRNewswire/ -- Patients with abdominal aortic aneurysms (AAAs) of less than 5.5 cm have no significant differences in clinical outcomes after endovascular repair (EVAR) than those with larger AAAs according to data from a five-year prospective clinical trial setting. The researchers maintain their recommendation that small aneurysms should not be treated surgically. Details of this study were presented at the 64th Vascular Annual Meeting presented by the Society for...

2010-06-04 08:00:00

IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA. John McDermott, President and CEO, said, "It is an honor to receive this award from TechAmerica. It is a...

2010-06-01 15:30:00

IRVINE, Calif., June 1 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the Jefferies 2010 Global Life Sciences Conference in New York, NY. Jefferies 2010 Global Life Sciences Event: Conference Date: Wednesday, June 9, 2010 Time:...

2010-05-21 08:00:00

IRVINE, Calif., May 21 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Thomas C. Wilder has joined the Endologix Board of Directors. Mr. Wilder was elected to the Board during the Company's 2010 Annual Meeting of Stockholders held on May 20, 2010. He replaces Paul McCormick, whose term on the Board expired at the Annual Meeting. With the addition of Mr. Wilder and the departure of Mr. McCormick,...

2010-05-19 16:15:00

CHICAGO, May 19 /PRNewswire/ -- Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm (AAA) repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina. Published in the June issue of the Society of Vascular Surgery's®, Journal of Vascular Surgery®, this retrospective review compares 401...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related